2021: an immunotherapy odyssey and the rise of nucleic acid nanotechnology
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
2021: an immunotherapy odyssey and the rise of nucleic acid nanotechnology
Authors
Keywords
-
Journal
Nanomedicine
Volume 16, Issue 19, Pages 1635-1640
Publisher
Future Medicine Ltd
Online
2021-06-25
DOI
10.2217/nnm-2021-0097
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The fate of nanoparticles in vivo and the strategy of designing stealth nanoparticle for drug delivery
- (2021) Jianwei Bao et al. CURRENT DRUG TARGETS
- Food and Drug Administration Beyond the 2001 Government Accountability Office Report: Promoting Drug Safety for Women
- (2021) Marjorie R. Jenkins et al. JOURNAL OF WOMENS HEALTH
- Induction of Cytokines by Nucleic Acid Nanoparticles (NANPs) Depends on the Type of Delivery Carrier
- (2021) Yelixza I. Avila et al. MOLECULES
- Opportunities, Barriers, and a Strategy for Overcoming Translational Challenges to Therapeutic Nucleic Acid Nanotechnology
- (2020) Kirill A. Afonin et al. ACS Nano
- Recent advances in mRNA vaccine technology
- (2020) Norbert Pardi et al. CURRENT OPINION IN IMMUNOLOGY
- A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice
- (2020) Dorottya Laczkó et al. IMMUNITY
- SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness
- (2020) Kizzmekia S. Corbett et al. NATURE
- Opportunities and challenges for the clinical translation of structured DNA assemblies as gene therapeutic delivery and vaccine vectors
- (2020) Marina A. Dobrovolskaia et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
- (2020) Ugur Sahin et al. NATURE
- The immunorecognition, subcellular compartmentalization, and physicochemical properties of nucleic acid nanoparticles can be controlled by composition modification
- (2020) Morgan Brittany Johnson et al. NUCLEIC ACIDS RESEARCH
- Toll-Like Receptor-Mediated Recognition of Nucleic Acid Nanoparticles (NANPs) in Human Primary Blood Cells
- (2019) Enping Hong et al. MOLECULES
- Aptamers as Modular Components of Therapeutic Nucleic Acid Nanotechnology
- (2019) Martin Panigaj et al. ACS Nano
- Nucleic Acid Nanoparticles at a Crossroads of Vaccines and Immunotherapies
- (2019) Marina A. Dobrovolskaia MOLECULES
- Orthogonal Protein-Responsive mRNA Switches for Mammalian Synthetic Biology
- (2019) Hiroki Ono et al. ACS Synthetic Biology
- Improved Nucleic Acid Therapy with Advanced Nanoscale Biotechnology
- (2019) Yuhua Weng et al. Molecular Therapy-Nucleic Acids
- Innate immune responses triggered by nucleic acids inspire the design of immunomodulatory nucleic acid nanoparticles (NANPs)
- (2019) Morgan Chandler et al. CURRENT OPINION IN BIOTECHNOLOGY
- Structure and Composition Define Immunorecognition of Nucleic Acid Nanoparticles
- (2018) Enping Hong et al. NANO LETTERS
- Recognition of Endogenous Nucleic Acids by the Innate Immune System
- (2016) Axel Roers et al. IMMUNITY
- Multifunctional RNA Nanoparticles
- (2014) Kirill A. Afonin et al. NANO LETTERS
- mRNA-based therapeutics — developing a new class of drugs
- (2014) Ugur Sahin et al. NATURE REVIEWS DRUG DISCOVERY
- Organization of Intracellular Reactions with Rationally Designed RNA Assemblies
- (2011) C. J. Delebecque et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now